Blood and Blood Components Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, End User, Application, Component Type

The blood and blood components market encompasses the collection, processing, storage, and distribution of whole blood and its derivatives. This market serves a critical role in healthcare, supporting a wide range of medical procedures, including surgeries, trauma care, and treatment of bleeding disorders. The value chain in this market involves blood donation centers, testing laboratories, storage facilities, and distribution networks, ensuring the safe and efficient delivery of blood products to end-users. Key applications include transfusion therapies, surgical procedures, and the development of biopharmaceuticals. Recent trends highlight the growing demand for plasma-derived products and the increasing adoption of advanced blood testing technologies.

The market is driven by the rising prevalence of chronic diseases and the increasing number of surgical procedures worldwide. However, challenges such as stringent regulatory requirements and the risk of transmission of infectious diseases remain significant barriers. The competitive landscape is characterized by the presence of several multinational corporations alongside regional players. Qualitative regional dynamics indicate a higher growth potential in emerging economies due to improved healthcare infrastructure and rising awareness about blood donation. Developed regions, meanwhile, continue to drive innovation and lead in the implementation of safety standards and technological advancements.

Key Insights
- The increasing prevalence of chronic diseases globally has led to a surge in demand for blood and its components, emphasizing the need for efficient collection and distribution systems. This trend is particularly pronounced in regions with aging populations and high incidence of lifestyle-related health conditions.
- Regulatory bodies continue to enforce stringent safety standards to minimize risks associated with blood transfusions. Compliance with these regulations is crucial for market players, ensuring public confidence and the safe handling of blood products.
- Technological advancements in blood testing and processing are gaining momentum, with innovations such as pathogen reduction technologies and automated blood collection devices enhancing efficiency and safety.
- Emerging economies are witnessing significant investments in healthcare infrastructure, leading to improved capabilities in blood collection and storage. This regional momentum is expected to drive market growth in these areas.
- Challenges persist in maintaining a stable supply of blood donations, with seasonal fluctuations and donor recruitment issues impacting availability. Efforts to raise awareness and encourage regular donations are critical to addressing these challenges.
- The competitive landscape features a mix of established multinational companies and local players, with strategic partnerships and mergers becoming common to expand market reach and capabilities.
- Demand for plasma-derived therapies is on the rise, driven by their effectiveness in treating a variety of conditions, including immune deficiencies and bleeding disorders. This segment is expected to see robust growth.
- North America and Europe remain at the forefront of implementing advanced blood safety protocols and technologies, setting benchmarks for other regions to follow and enhancing overall market standards.
- Strategic collaborations between healthcare providers and technology firms are fostering innovation in blood component management, leading to improved patient outcomes and operational efficiencies.
- Efforts to promote voluntary blood donation and improve donor retention are gaining traction, with campaigns focusing on the altruistic and societal benefits of donating blood, particularly in regions with low donor participation rates.
Market Segmentation
- Product Type
- Whole Blood
- Red Blood Cells
- Plasma
- Platelets

- End User
- Hospitals
- Blood Banks
- Diagnostic Laboratories
- Research Institutes

- Application
- Therapeutic Applications
- Research Applications
- Diagnostics

- Component Type
- Plasma-Derived Components
- Cellular Components

Key Companies Analysed
- Terumo Corporation
- Fresenius Kabi AG
- Grifols S.A.
- Haemonetics Corporation
- Macopharma SA
- Immucor, Inc.
- Medline Industries, Inc.
- CSL Limited
- Kawasumi Laboratories, Inc.
- Octapharma AG
- Biotest AG
- JMS Co., Ltd.
- B. Braun Melsungen AG
- Sartorius AG
- Terumo BCT
- Fenwal, Inc.
- MacoPharma International GmbH
- American Red Cross
- Blood Centers of America
- Sanquin
- Terumo Penpol Ltd.
- Roche Diagnostics
- Abbott Laboratories
- Beckman Coulter, Inc.
- Ortho Clinical Diagnostics
This report is designed for decision-makers who need more than a surface-level market snapshot. It combines rigorous analytical methods-Porter’s Five Forces, value chain mapping, supply-demand assessment, and scenario-based modelling-to translate complex market signals into clear, actionable intelligence. Beyond the core market, the analysis evaluates cross-sector influences from parent, derived, and substitute markets to reveal hidden dependencies, exposure points, and demand spillovers that can materially affect strategy.

Clients benefit from a clearer view of “what is driving what” in the ecosystem: trade and pricing analytics track international flows, key importing and exporting regions, and evolving regional price signals that shape profitability and sourcing decisions. Forecast scenarios integrate macroeconomic conditions, policy and regulatory direction (including carbon pricing and energy security priorities), and shifting customer behaviour, enabling leadership teams to stress-test plans, prioritize investments, and build resilient go-to-market and supply strategies with greater confidence.

Blood and Blood Components Market Competitive Intelligence Built for Strategic Advantage
The report delivers a structured, decision-ready view of the competitive landscape using proprietary frameworks. It profiles leading companies across business models, product and service portfolios, operational footprints, financial performance indicators, and strategic priorities-helping clients benchmark competitors and identify capability gaps. Critical competitive moves such as mergers and acquisitions, technology collaborations, investment inflows, and regional expansions are analysed for their real implications on market power, differentiation, and route-to-market strength.

Clients can use these insights to sharpen positioning, validate partnership targets, and anticipate competitor moves before they impact pricing, access, or share. The report also highlights emerging players and innovation-led startups that are reshaping customer expectations and accelerating disruption. Regional intelligence pinpoints attractive investment destinations, evolving regulatory environments, and partnership ecosystems across key energy and industrial corridors-supporting smarter market entry, expansion sequencing, and risk-managed growth strategies.

Countries Covered
- North America - Market data and outlook to 2034
- United States
- Canada
- Mexico

- Europe - Market data and outlook to 2034
- Germany
- United Kingdom
- France
- Italy
- Spain
- Netherlands
- Switzerland
- Poland
- Sweden
- Russia

- Asia-Pacific - Market data and outlook to 2034
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Malaysia
- Vietnam

- Middle East and Africa - Market data and outlook to 2034
- Saudi Arabia
- South Africa
- Iran
- UAE
- Egypt

- South and Central America - Market data and outlook to 2034
- Brazil
- Argentina
- Chile
- Peru

Blood and Blood Components Market Report (2024-2034): Research Methodology Built for Confident Decisions
This market report is developed using a robust, buyer-ready research process that blends primary interviews with domain experts across the Blood and Blood Components value chain and deep secondary research from industry associations, government publications, trade databases, and verified company disclosures. Our analysts apply proprietary modeling techniques-including data triangulation, statistical correlation, and scenario planning-to validate assumptions and deliver dependable market sizing, segmentation, and forecasting outcomes.

For clients, this means the insights are not just descriptive-they are built to support high-stakes decisions such as market entry, capacity planning, pricing and sourcing strategy, competitive positioning, and investment prioritization. The result is a market intelligence package that reduces uncertainty, highlights where the market is going next, and explains the “why” behind the numbers.

Key Strategic Questions Answered in the Blood and Blood Components Market Study (2024-2034)
This section brings together the most important client questions and the report’s core deliverables in one place-so you can quickly see how the study supports decisions on market entry, expansion, sourcing, pricing, partnerships, and investment. It provides global-to-country level visibility, segment-level prioritisation, supply chain and trade clarity, and competitive benchmarking-so stakeholders can move from market understanding to confident action.

- Market size, share, and forecast clarity: Current and forecast Blood and Blood Components market size at global, regional, and country levels, including coverage across 5 regions and 27 countries (2024-2034), with the key forces shaping the trajectory.
- High-growth segment identification: Which types, products, applications, technologies, and end-user verticals are positioned for the fastest growth-supported by market size, share, and growth outlook (2024-2034).
- Supply chain resilience and cost impact:(covered as paid customisation) How supply chains are adapting to geopolitical disruptions, sanctions risks, and macroeconomic volatility, including implications for availability, lead times, and cost structure-supported by value chain/supply chain mapping.
- Trade flows and pricing intelligence: Practical “commercial reality checks” with trade analytics, pricing/price-trend analysis, and supply-demand dynamics to support sourcing, pricing strategy, and regional prioritisation.
- Geopolitical impact assessment: Scenario-based evaluation of how major conflict and tension zones (including Russia-Ukrainebroader Middle East dynamics, as well as wider energy and commodity corridor disruptions) influence trade routes, input costs, and supply continuity.
- Policy and sustainability lens: How regulatory frameworks, trade policies, and sustainability targets reshape demand patterns, customer requirements, and investment timing-helping clients anticipate compliance and capture advantage early.
- Competitive landscape and strategic benchmarking: Porter’s Five Forces, technology developments, and competitive positioning-plus profiles of 5 leading companies covering overview, product focus, key strategies, and financial snapshots.
- Regional hotspots and go-to-market guidance: Which regions and customer segments are likely to outperform-and which go-to-market, channel, and partnership models best support entry, scaling, and defensible positioning.
- Investable opportunities and 3-5 year priorities: Where the most attractive opportunities sit across technology roadmaps, sustainability-linked innovation, and M& A, and which segments are best positioned for near- to mid-term investment decisions.
- Latest market developments: A structured view of recent announcements, partnerships, expansions, and strategic moves shaping the Blood and Blood Components competitive environment-so clients can act on shifts early.
Additional Support
With the purchase of this report, you will receive:
- An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
- 7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
- Complimentary report update to incorporate the latest available data and the impact of recent market developments.

This product will be delivered within 1-3 business days.